88. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Donnerstag, 21. April 2022 (Posterbereich 13) 09:30-11:00

Postervorträge

Vorhofflimmern - Varia

Diskussionsleitung: M. Antz (Braunschweig), J. Lüker (Köln)

(P478) Empirical Superior Vena Cava Isolation in Patients Undergoing Repeat Catheter Ablation Procedure After Recurrence of Atrial Fibrillation
    J. Müller, G. Simu, K. Nentwich, A. Berkovitz, E. Ene, K. Sonne, I. Chakarov, M. Cacic, T. Deneke (Bad Neustadt a. d. Saale)
(P479) Psychological assessment in patients with atrial fibrillation undergoing pulmonary vein isolation
    V. Pavlicek, S. Wedegärtner, D. Millenaar, J. Wintrich, I. Kindermann, M. Böhm, C. Ukena (Homburg/Saar)
(P480) Identifying type of atrial fibrillation by cardiovascular biomarker level
    M. Zink, B. Hermans, M. Gramlich, S. Philippens, K. Vernooy, A. van Hunnik, D. Linz, S. Zeemering, U. Schotten (Aachen; Maastricht, NL)
(P481) Association of atrial fibrillation recurrence within one year after ablation with preprocedural cardiovascular biomarker levels
    M. Zink, B. Hermans, M. Gramlich, S. Philippens, K. Vernooy, A. van Hunnik, D. Linz, S. Zeemering, U. Schotten (Aachen; Maastricht, NL)
(P482) Akuter Prozedurerfolg und Komplikationsrate der Alkoholablation des Marshall Ligament bei persistierendem Vorhofflimmern
    O. Krahnefeld, T. Agdirlioglu, P. Poley, J. Weil (Lübeck)
(P483) Prognostic significance of atrial tachycardia recurrence after catheter ablation for persistent atrial fibrillation
    M.-A. Popa, F. Bourier, T. Reents, M. Kottmaier, S. Lengauer, M. Telishevska, S. J. Maurer, H. Krafft, E. Risse, F. Bahlke, F. Englert, G. Heßling, I. Deisenhofer (München)
(P484) Association of altered left atrial anatomy in mitral valve disease on safety outcomes in left atrial appendage closure
    S. Kany, J. Skibowski, C.-H. Müller, V. Geist, H. Nef, F. Niroomand, B. Hailer, S. T. Pleger, I. Akin, M. Hochadel, J. Senges, E. Lubos (Hamburg, Lüneburg, Bad Segeberg, Gießen, Heidelberg, Essen, Mannheim, Ludwigshafen am Rhein)
(P485) Dapagliflozin but not empagliflozin suppresses atrial fibrillation in an experimental perfused whole-heart model
    C. Ellermann, J. Uphoff, J. Wolfes, K. Willy, F. K. Wegner, F. Reinke, P. S. Lange, L. Eckardt, G. Frommeyer (Münster)